Journal of Hepatology
Volume 51, Issue 3 , Pages 557-564 , September 2009

Hepatocyte GP73 expression in Wilson disease

  • Lorinda M. Wright

      Affiliations

    • Division of Gastroenterology, Hepatology and Nutrition, Loyola University Medical Center, 2160 South 1st Ave., Maywood, IL 60153, USA
    • Hines VA Medical Center, Hines, IL, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 708 2025717; fax: +1 7082164113.
    • ,
  • Dominik Huster

      Affiliations

    • Department of Medicine II, University of Leipzig, Leipzig, Germany
    • ,
  • Svetlana Lutsenko

      Affiliations

    • Department of Biochemistry and Molecular Biology, Oregon Health & Science University, Portland, OR, USA
    • ,
  • Fritz Wrba

      Affiliations

    • Department of Clinical Pathology, Medical University of Vienna, Vienna, Austria
    • ,
  • Peter Ferenci

      Affiliations

    • Department of Internal Medicine 4, Medical University of Vienna, Vienna, Austria
    • ,
  • Claus J. Fimmel

      Affiliations

    • Division of Gastroenterology, Hepatology and Nutrition, Loyola University Medical Center, 2160 South 1st Ave., Maywood, IL 60153, USA
    • Hines VA Medical Center, Hines, IL, USA

Received 5 January 2009 ,Revised 29 April 2009 ,Accepted 25 May 2009.

References 

  1. Iftikhar R, Kladney RD, Havlioglu N, Schmitt-Graff A, Gusmirovic I, Solomon H, et al. Disease- and cell-specific expression of GP73 in human liver disease. Am J Gastroenterol. 2004;99:1087
  2. Kladney RD, Bulla GA, Guo L, Mason AL, Tollefson AE, Simon DJ, et al. GP73, a novel Golgi-localized protein upregulated by viral infection. Gene. 2000;249:53
  3. Kladney RD, Cui X, Bulla GA, Brunt EM, Fimmel CJ. Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease. Hepatology. 2002;35:1431
  4. Bachert C, Fimmel C, Linstedt AD. Endosomal trafficking and proprotein convertase cleavage of cis Golgi protein GP73 produces marker for hepatocellular carcinoma. Traffic. 2007;8:1415
  5. Marrero JA, Romano PR, Nikolaeva O, Steel L, Mehta A, Fimmel CJ, et al. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma. J Hepatol. 2005;43:1007
  6. Ferenci P. Wilson’s disease. Clin Gastroenterol Hepatol. 2005;3:726
  7. Ferenci P, Caca K, Loudianos G, Mieli-Vergani G, Tanner S, Sternlieb I, et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int. 2003;23:139
  8. Ferenci P, Steindl-Munda P, Vogel W, Jessner W, Gschwantler M, Stauber R, et al. Diagnostic value of quantitative hepatic copper determination in patients with Wilson’s disease. Clin Gastroenterol Hepatol. 2005;3:811
  9. Kingston HM, Jassie LB. Microwave energy for acid decomposition at elevated temperatures and pressures using biological and botanical samples. Anal Chem. 1986;58:2534
  10. Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol. 1995;19:1409
  11. Buiakova OI, Xu J, Lutsenko S, Zeitlin S, Das K, Das S, et al. Null mutation of the murine ATP7B (Wilson disease) gene results in intracellular copper accumulation and late-onset hepatic nodular transformation. Hum Mol Genet. 1999;8:1665
  12. Huster D, Finegold MJ, Morgan CT, Burkhead JL, Nixon R, Vanderwerf SM, et al. Consequences of copper accumulation in the livers of the Atp7b-/- (Wilson disease gene) knockout mice. Am J Pathol. 2006;168:423
  13. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402
  14. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 2002;30:e36
  15. de Bie P, Muller P, Wijmenga C, Klomp LW. Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes. J Med Genet. 2007;44:673
  16. Panagiotakaki E, Tzetis M, Manolaki N, Loudianos G, Papatheodorou A, Manesis E, et al. Genotype–phenotype correlations for a wide spectrum of mutations in the Wilson disease gene (ATP7B). Am J Med Genet A. 2004;131:168
  17. Steindl P, Ferenci P, Dienes HP, Grimm G, Pabinger I, Madl C, et al. Wilson’s disease in patients presenting with liver disease: a diagnostic challenge. Gastroenterology. 1997;113:212
  18. Fox PL, Mukhopadhyay C, Ehrenwald E. Structure, oxidant activity, and cardiovascular mechanisms of human ceruloplasmin. Life Sci. 1995;56:1749
  19. Ritland S, Skrede S, Johansen O. A long-term follow-up study of the hepatic copper and serum ceruloplasmin concentrations in patients with chronic liver disease. Scand J Gastroenterol. 1982;17:545
  20. Wright LM, Yong S, Picken MM, Rockey D, Fimmel CJ. Decreased survival and hepato-renal pathology in mice with C-terminally truncated GP73 (GOLPH2). Int J Clin Exp Pathol. 2009;2:34
  21. Ferenci P. Pathophysiology and clinical features of Wilson disease. Metab Brain Dis. 2004;19:229
  22. Nagasaka H, Inoue I, Inui A, Komatsu H, Sogo T, Murayama K, et al. Relationship between oxidative stress and antioxidant systems in the liver of patients with Wilson disease: hepatic manifestation in Wilson disease as a consequence of augmented oxidative stress. Pediatr Res. 2006;60:472
  23. Samuele A, Mangiagalli A, Armentero MT, Fancellu R, Bazzini E, Vairetti M, et al. Oxidative stress and pro-apoptotic conditions in a rodent model of Wilson’s disease. Biochim Biophys Acta. 2005;1741:325
  24. Lu Y, Yi Y, Liu P, Wen W, James M, Wang D, et al. Common human cancer genes discovered by integrated gene-expression analysis. PLoS ONE. 2007;2:e1149
  25. Varambally S, Laxman B, Mehra R, Cao Q, Dhanasekaran SM, Tomlins SA, et al. Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer. Neoplasia. 2008;10:1285
  26. Iwadate H, Ohira H, Suzuki T, Abe K, Yokokawa J, Takiguchi J, et al. Hepatocellular carcinoma associated with Wilson’s disease. Intern Med. 2004;43:1042
  27. Xu R, Bu-Ghanim M, Fiel MI, Schiano T, Cohen E, Thung SN. Hepatocellular carcinoma associated with an atypical presentation of Wilson’s disease. Semin Liver Dis. 2007;27:122
  28. Huster D, Purnat TD, Burkhead JL, Ralle M, Fiehn O, Stuckert F, et al. High copper selectively alters lipid metabolism and cell cycle machinery in the mouse model of Wilson disease. J Biol Chem. 2007;282:8343
  29. Puri S, Bachert C, Fimmel CJ, Linstedt AD. Cycling of early Golgi proteins via the cell surface and endosomes upon lumenal pH disruption. Traffic. 2002;3:641
  30. Lim CM, Cater MA, Mercer JF, La Fontaine S. Copper-dependent interaction of dynactin subunit p62 with the N-terminus of ATP7B but not ATP7A. J Biol Chem. 2006;281:14006

☆ This study was supported by an NIH grant (R21 DK075659) to S.L. The authors who have taken part in this study declared that they do not have anything to disclose regarding funding or conflict of interest with respect to this manuscript.

PII: S0168-8278(09)00398-5

doi: 10.1016/j.jhep.2009.05.029

Journal of Hepatology
Volume 51, Issue 3 , Pages 557-564 , September 2009

Article Tools

* Image Usage & Resolution